ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bispecific Antibodies Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-34F9938
Home | Market Reports | Health| Pharmacy
Global Bispecific Antibodies Market Insights Forecast to 2028
BUY CHAPTERS

Global Bispecific Antibodies Market Research Report 2025

Code: QYRE-Auto-34F9938
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche Holding AG
GenScript
Sino Biological Inc
Creative-Biolabs
AbbVie
Astrazeneca plc
Amgen Inc
Pfizer Inc
Novartis
Johnson & Johnson
ProteoGenix
Kymab
BIOCYTOGEN

Bispecific Antibodies Market Size

The global market for Bispecific Antibodies was valued at US$ 3498 million in the year 2024 and is projected to reach a revised size of US$ 4405 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Bispecific Antibodies Market

Bispecific Antibodies Market

A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibodies.
The Bispecific Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bispecific Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Bispecific Antibodies Market Report

Report Metric Details
Report Name Bispecific Antibodies Market
Accounted market size in year US$ 3498 million
Forecasted market size in 2031 US$ 4405 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche Holding AG, GenScript, Sino Biological Inc., Creative-Biolabs, AbbVie Inc., Kymab, AstraZeneca, BIOCYTOGEN, Amgen Inc., Pfizer Inc., Novartis AG, Johnson & Johnson, ProteoGenix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Bispecific Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Bispecific Antibodies Market growing?

Ans: The Bispecific Antibodies Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Bispecific Antibodies Market size in 2031?

Ans: The Bispecific Antibodies Market size in 2031 will be US$ 4405 million.

What is the market share of major companies in Bispecific Antibodies Market?

Ans: Global top five manufacturers hold a share over 95%.

Who are the main players in the Bispecific Antibodies Market report?

Ans: The main players in the Bispecific Antibodies Market are Roche Holding AG, GenScript, Sino Biological Inc., Creative-Biolabs, AbbVie Inc., Kymab, AstraZeneca, BIOCYTOGEN, Amgen Inc., Pfizer Inc., Novartis AG, Johnson & Johnson, ProteoGenix

What are the Application segmentation covered in the Bispecific Antibodies Market report?

Ans: The Applications covered in the Bispecific Antibodies Market report are Cancer, Infectious Disease, Inflammatory and Autoimmune Disorders, CNS Disorders

What are the Type segmentation covered in the Bispecific Antibodies Market report?

Ans: The Types covered in the Bispecific Antibodies Market report are Blinatumab, Catumaxomab, Duligotumab

Recommended Reports

Bispecific Antibodies

Antibody Therapeutics

Diagnostics & Drug Delivery

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bispecific Antibodies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blinatumab
1.2.3 Catumaxomab
1.2.4 Duligotumab
1.3 Market by Application
1.3.1 Global Bispecific Antibodies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Disease
1.3.4 Inflammatory and Autoimmune Disorders
1.3.5 CNS Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bispecific Antibodies Market Perspective (2020-2031)
2.2 Global Bispecific Antibodies Growth Trends by Region
2.2.1 Global Bispecific Antibodies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bispecific Antibodies Historic Market Size by Region (2020-2025)
2.2.3 Bispecific Antibodies Forecasted Market Size by Region (2026-2031)
2.3 Bispecific Antibodies Market Dynamics
2.3.1 Bispecific Antibodies Industry Trends
2.3.2 Bispecific Antibodies Market Drivers
2.3.3 Bispecific Antibodies Market Challenges
2.3.4 Bispecific Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bispecific Antibodies Players by Revenue
3.1.1 Global Top Bispecific Antibodies Players by Revenue (2020-2025)
3.1.2 Global Bispecific Antibodies Revenue Market Share by Players (2020-2025)
3.2 Global Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bispecific Antibodies Revenue
3.4 Global Bispecific Antibodies Market Concentration Ratio
3.4.1 Global Bispecific Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bispecific Antibodies Revenue in 2024
3.5 Global Key Players of Bispecific Antibodies Head office and Area Served
3.6 Global Key Players of Bispecific Antibodies, Product and Application
3.7 Global Key Players of Bispecific Antibodies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bispecific Antibodies Breakdown Data by Type
4.1 Global Bispecific Antibodies Historic Market Size by Type (2020-2025)
4.2 Global Bispecific Antibodies Forecasted Market Size by Type (2026-2031)
5 Bispecific Antibodies Breakdown Data by Application
5.1 Global Bispecific Antibodies Historic Market Size by Application (2020-2025)
5.2 Global Bispecific Antibodies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bispecific Antibodies Market Size (2020-2031)
6.2 North America Bispecific Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bispecific Antibodies Market Size by Country (2020-2025)
6.4 North America Bispecific Antibodies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bispecific Antibodies Market Size (2020-2031)
7.2 Europe Bispecific Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bispecific Antibodies Market Size by Country (2020-2025)
7.4 Europe Bispecific Antibodies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bispecific Antibodies Market Size (2020-2031)
8.2 Asia-Pacific Bispecific Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bispecific Antibodies Market Size by Region (2020-2025)
8.4 Asia-Pacific Bispecific Antibodies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bispecific Antibodies Market Size (2020-2031)
9.2 Latin America Bispecific Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bispecific Antibodies Market Size by Country (2020-2025)
9.4 Latin America Bispecific Antibodies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bispecific Antibodies Market Size (2020-2031)
10.2 Middle East & Africa Bispecific Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bispecific Antibodies Market Size by Country (2020-2025)
10.4 Middle East & Africa Bispecific Antibodies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Holding AG
11.1.1 Roche Holding AG Company Details
11.1.2 Roche Holding AG Business Overview
11.1.3 Roche Holding AG Bispecific Antibodies Introduction
11.1.4 Roche Holding AG Revenue in Bispecific Antibodies Business (2020-2025)
11.1.5 Roche Holding AG Recent Development
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript Bispecific Antibodies Introduction
11.2.4 GenScript Revenue in Bispecific Antibodies Business (2020-2025)
11.2.5 GenScript Recent Development
11.3 Sino Biological Inc.
11.3.1 Sino Biological Inc. Company Details
11.3.2 Sino Biological Inc. Business Overview
11.3.3 Sino Biological Inc. Bispecific Antibodies Introduction
11.3.4 Sino Biological Inc. Revenue in Bispecific Antibodies Business (2020-2025)
11.3.5 Sino Biological Inc. Recent Development
11.4 Creative-Biolabs
11.4.1 Creative-Biolabs Company Details
11.4.2 Creative-Biolabs Business Overview
11.4.3 Creative-Biolabs Bispecific Antibodies Introduction
11.4.4 Creative-Biolabs Revenue in Bispecific Antibodies Business (2020-2025)
11.4.5 Creative-Biolabs Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Details
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. Bispecific Antibodies Introduction
11.5.4 AbbVie Inc. Revenue in Bispecific Antibodies Business (2020-2025)
11.5.5 AbbVie Inc. Recent Development
11.6 Kymab
11.6.1 Kymab Company Details
11.6.2 Kymab Business Overview
11.6.3 Kymab Bispecific Antibodies Introduction
11.6.4 Kymab Revenue in Bispecific Antibodies Business (2020-2025)
11.6.5 Kymab Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Bispecific Antibodies Introduction
11.7.4 AstraZeneca Revenue in Bispecific Antibodies Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 BIOCYTOGEN
11.8.1 BIOCYTOGEN Company Details
11.8.2 BIOCYTOGEN Business Overview
11.8.3 BIOCYTOGEN Bispecific Antibodies Introduction
11.8.4 BIOCYTOGEN Revenue in Bispecific Antibodies Business (2020-2025)
11.8.5 BIOCYTOGEN Recent Development
11.9 Amgen Inc.
11.9.1 Amgen Inc. Company Details
11.9.2 Amgen Inc. Business Overview
11.9.3 Amgen Inc. Bispecific Antibodies Introduction
11.9.4 Amgen Inc. Revenue in Bispecific Antibodies Business (2020-2025)
11.9.5 Amgen Inc. Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Details
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Bispecific Antibodies Introduction
11.10.4 Pfizer Inc. Revenue in Bispecific Antibodies Business (2020-2025)
11.10.5 Pfizer Inc. Recent Development
11.11 Novartis AG
11.11.1 Novartis AG Company Details
11.11.2 Novartis AG Business Overview
11.11.3 Novartis AG Bispecific Antibodies Introduction
11.11.4 Novartis AG Revenue in Bispecific Antibodies Business (2020-2025)
11.11.5 Novartis AG Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Bispecific Antibodies Introduction
11.12.4 Johnson & Johnson Revenue in Bispecific Antibodies Business (2020-2025)
11.12.5 Johnson & Johnson Recent Development
11.13 ProteoGenix
11.13.1 ProteoGenix Company Details
11.13.2 ProteoGenix Business Overview
11.13.3 ProteoGenix Bispecific Antibodies Introduction
11.13.4 ProteoGenix Revenue in Bispecific Antibodies Business (2020-2025)
11.13.5 ProteoGenix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche Holding AG
GenScript
Sino Biological Inc
Creative-Biolabs
AbbVie
Astrazeneca plc
Amgen Inc
Pfizer Inc
Novartis
Johnson & Johnson
ProteoGenix
Kymab
BIOCYTOGEN
List of Tables
 Table 1. Global Bispecific Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Blinatumab
 Table 3. Key Players of Catumaxomab
 Table 4. Key Players of Duligotumab
 Table 5. Global Bispecific Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Bispecific Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Bispecific Antibodies Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Bispecific Antibodies Market Share by Region (2020-2025)
 Table 9. Global Bispecific Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Bispecific Antibodies Market Share by Region (2026-2031)
 Table 11. Bispecific Antibodies Market Trends
 Table 12. Bispecific Antibodies Market Drivers
 Table 13. Bispecific Antibodies Market Challenges
 Table 14. Bispecific Antibodies Market Restraints
 Table 15. Global Bispecific Antibodies Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Bispecific Antibodies Market Share by Players (2020-2025)
 Table 17. Global Top Bispecific Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibodies as of 2024)
 Table 18. Ranking of Global Top Bispecific Antibodies Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Bispecific Antibodies Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Bispecific Antibodies, Headquarters and Area Served
 Table 21. Global Key Players of Bispecific Antibodies, Product and Application
 Table 22. Global Key Players of Bispecific Antibodies, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Bispecific Antibodies Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Bispecific Antibodies Revenue Market Share by Type (2020-2025)
 Table 26. Global Bispecific Antibodies Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Bispecific Antibodies Revenue Market Share by Type (2026-2031)
 Table 28. Global Bispecific Antibodies Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Bispecific Antibodies Revenue Market Share by Application (2020-2025)
 Table 30. Global Bispecific Antibodies Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Bispecific Antibodies Revenue Market Share by Application (2026-2031)
 Table 32. North America Bispecific Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Bispecific Antibodies Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Bispecific Antibodies Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Bispecific Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Bispecific Antibodies Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Bispecific Antibodies Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Bispecific Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Bispecific Antibodies Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Bispecific Antibodies Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Bispecific Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Bispecific Antibodies Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Bispecific Antibodies Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Bispecific Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Bispecific Antibodies Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Bispecific Antibodies Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Roche Holding AG Company Details
 Table 48. Roche Holding AG Business Overview
 Table 49. Roche Holding AG Bispecific Antibodies Product
 Table 50. Roche Holding AG Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 51. Roche Holding AG Recent Development
 Table 52. GenScript Company Details
 Table 53. GenScript Business Overview
 Table 54. GenScript Bispecific Antibodies Product
 Table 55. GenScript Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 56. GenScript Recent Development
 Table 57. Sino Biological Inc. Company Details
 Table 58. Sino Biological Inc. Business Overview
 Table 59. Sino Biological Inc. Bispecific Antibodies Product
 Table 60. Sino Biological Inc. Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 61. Sino Biological Inc. Recent Development
 Table 62. Creative-Biolabs Company Details
 Table 63. Creative-Biolabs Business Overview
 Table 64. Creative-Biolabs Bispecific Antibodies Product
 Table 65. Creative-Biolabs Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 66. Creative-Biolabs Recent Development
 Table 67. AbbVie Inc. Company Details
 Table 68. AbbVie Inc. Business Overview
 Table 69. AbbVie Inc. Bispecific Antibodies Product
 Table 70. AbbVie Inc. Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 71. AbbVie Inc. Recent Development
 Table 72. Kymab Company Details
 Table 73. Kymab Business Overview
 Table 74. Kymab Bispecific Antibodies Product
 Table 75. Kymab Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 76. Kymab Recent Development
 Table 77. AstraZeneca Company Details
 Table 78. AstraZeneca Business Overview
 Table 79. AstraZeneca Bispecific Antibodies Product
 Table 80. AstraZeneca Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 81. AstraZeneca Recent Development
 Table 82. BIOCYTOGEN Company Details
 Table 83. BIOCYTOGEN Business Overview
 Table 84. BIOCYTOGEN Bispecific Antibodies Product
 Table 85. BIOCYTOGEN Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 86. BIOCYTOGEN Recent Development
 Table 87. Amgen Inc. Company Details
 Table 88. Amgen Inc. Business Overview
 Table 89. Amgen Inc. Bispecific Antibodies Product
 Table 90. Amgen Inc. Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 91. Amgen Inc. Recent Development
 Table 92. Pfizer Inc. Company Details
 Table 93. Pfizer Inc. Business Overview
 Table 94. Pfizer Inc. Bispecific Antibodies Product
 Table 95. Pfizer Inc. Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 96. Pfizer Inc. Recent Development
 Table 97. Novartis AG Company Details
 Table 98. Novartis AG Business Overview
 Table 99. Novartis AG Bispecific Antibodies Product
 Table 100. Novartis AG Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 101. Novartis AG Recent Development
 Table 102. Johnson & Johnson Company Details
 Table 103. Johnson & Johnson Business Overview
 Table 104. Johnson & Johnson Bispecific Antibodies Product
 Table 105. Johnson & Johnson Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 106. Johnson & Johnson Recent Development
 Table 107. ProteoGenix Company Details
 Table 108. ProteoGenix Business Overview
 Table 109. ProteoGenix Bispecific Antibodies Product
 Table 110. ProteoGenix Revenue in Bispecific Antibodies Business (2020-2025) & (US$ Million)
 Table 111. ProteoGenix Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Bispecific Antibodies Picture
 Figure 2. Global Bispecific Antibodies Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bispecific Antibodies Market Share by Type: 2024 VS 2031
 Figure 4. Blinatumab Features
 Figure 5. Catumaxomab Features
 Figure 6. Duligotumab Features
 Figure 7. Global Bispecific Antibodies Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Bispecific Antibodies Market Share by Application: 2024 VS 2031
 Figure 9. Cancer Case Studies
 Figure 10. Infectious Disease Case Studies
 Figure 11. Inflammatory and Autoimmune Disorders Case Studies
 Figure 12. CNS Disorders Case Studies
 Figure 13. Bispecific Antibodies Report Years Considered
 Figure 14. Global Bispecific Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Bispecific Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Bispecific Antibodies Market Share by Region: 2024 VS 2031
 Figure 17. Global Bispecific Antibodies Market Share by Players in 2024
 Figure 18. Global Top Bispecific Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibodies as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Bispecific Antibodies Revenue in 2024
 Figure 20. North America Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Bispecific Antibodies Market Share by Country (2020-2031)
 Figure 22. United States Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Bispecific Antibodies Market Share by Country (2020-2031)
 Figure 26. Germany Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Bispecific Antibodies Market Share by Region (2020-2031)
 Figure 34. China Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Bispecific Antibodies Market Share by Country (2020-2031)
 Figure 42. Mexico Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Bispecific Antibodies Market Share by Country (2020-2031)
 Figure 46. Turkey Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Bispecific Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Roche Holding AG Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 50. GenScript Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 51. Sino Biological Inc. Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 52. Creative-Biolabs Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 53. AbbVie Inc. Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 54. Kymab Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 55. AstraZeneca Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 56. BIOCYTOGEN Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 57. Amgen Inc. Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 58. Pfizer Inc. Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 59. Novartis AG Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 60. Johnson & Johnson Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 61. ProteoGenix Revenue Growth Rate in Bispecific Antibodies Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Bispecific Antibody Therapeutic Market Insights Forecast to 2030
Bi Specific Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Monoclonal Antibodies Market Research Report 2024
Global Bi Specific Antibodies Therapy Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Bispecific Antibodies Drug Market Research Report 2025
Global Bi Specific MAbS Market Research Report 2024
Global Bispecific Antibody Development Platform Market Research Report 2024
Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030
Global Bispecific Antibody Molecular Drug Market Research Report 2025
Global T Cell NK Cell Engaging Bispecific Antibodies Market Research Report 2025
Global Humanized Bispecific Antibody Market Research Report 2024
Global Humanized Bispecific Antibodies Market Research Report 2024
Global BCMA CD3 Bispecific Antibody Market Research Report 2024
BAF53 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Single Domain Antibody sdAbs Drugs Market Research Report 2024
Global Next Generation Antibody Therapeutics Market Research Report 2025
Global Cell bridging Bispecific Antibodies Market Research Report 2025
Global Bcl 2 Antibody Market Research Report 2024
P53 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
UBA6 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions